Mindfulness-based therapy versus cognitive behavioral therapy for people with anxiety symptoms: a systematic review and meta-analysis of random controlled trials
Jingjing Li, Zhu Cai, Xiaoming Li, Rongrong Du, Zhulin Shi, Qiang Hua, Mao Zhang, Chunyan Zhu, Lei Zhang, Xiujun Zhan
Annals of Palliative Medicine July 1, 2021 DOI: 10.21037/apm-21-1212 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractMindfulness-based interventions and cognitive behavioral therapy are similarly effective for reducing anxiety, depression, and improving sleep quality. A meta-analysis of 11 randomized controlled trials found no significant difference between the two approaches on these outcomes after treatment. Subgroup analyses suggested that mindfulness-based interventions may offer a small advantage for general anxiety symptoms, while CBT showed a small advantage for social anxiety measured by specific scales. Mindfulness-based stress reduction also showed a slight benefit compared to other mindfulness types. The findings indicate that mindfulness-based interventions can serve as an alternative to CBT for treating anxiety symptoms.
Study at a glance
| Characteristics | Meta-analysis Randomized Peer reviewed |
|---|---|
| Population | Patients with anxiety disorders or symptoms of anxiety, including those with physical or mental disorders with comorbid anxiety symptoms |
| Topics | Anxiety Meditation |
| Keywords | Randomized controlled trial Meta-analysis Cochrane library Cognitive behavioral therapy |
| Citations | 58 |
| Key finding | No significant difference between mindfulness-based interventions and cognitive behavioral therapy in treating anxiety, depression, and sleep quality post-intervention. |
Abstract
BACKGROUND: Mindfulness-based interventions (MBIs) and cognitive behavioral therapy (CBT) have both been shown to be effective treatment approaches for anxiety. The purpose of this paper was to directly investigate the ability of MBIs and CBT to improve anxiety symptoms (primary outcome), as well as depression symptoms and sleep quality (second outcome). METHODS: We searched the following electronic databases from 1st December, 2019 to 14th January 2021: English databases including PubMed, PsycINFO, Web of Science, the Cochrane Library, Elsevier, Springer Link, Wiley Online Library, ClinicalTrails, and Embase, and Chinese database including CNKI, WANFANG, and CQVIP. The eligibility criteria included the following: (I) patients with anxiety disorders or symptoms of anxiety; and those with physical or mental disorders with comorbid anxiety symptoms; (II) randomized controlled trial (RCT) design; (III) the treatment group received MBIs; (IV) the control group received CBT; and (V) the treatment outcomes were anxiety, depression, and sleep quality. RESULTS: In total, 4,095 abstracts were reviewed. Of these, the full-texts of 45 articles were read in detail; and 11 RCTs were finally included in the analysis. Upon completion of MBIs and CBT group sessions, the study outcomes (mean anxiety, depression, and sleep quality scores) revealed no difference between MBIs and CBT with regards to anxiety, depression, and sleep quality post-intervention. Subgroup analysis was also performed, and the results indicated that MBIs may provide a small advantage for people with anxiety symptoms compared to CBT [standard mean difference (SMD): -0.36, 95% confidence interval (CI): -0.66 to -0.06], while the CBT group demonstrated a small comparative advantage for anxiety in the Liebowitz Social Anxiety Scale (LSAS) and Social Phobia Inventory (SPIN) scales, as well as mindfulness-based stress reduction (MBSR) in the types of MBIs (LSAS: SMD: 0.35, 95% CI: 0.08 to 0.63; SPIN: SMD: 0.51, 95% CI: 0.11 to 0.92; MBSR: SMD: 0.41, 95% CI: 0.07 to 0.74). DISCUSSION: There was no significant difference between MBIs and CBT in terms of the treatment outcomes of anxiety, depression, and sleep quality. MBIs could be used as an alternative intervention to CBT for anxiety symptoms. TRIAL REGISTRATION: This meta-analysis was conducted in line with the PRISMA guideline and was registered at PROSPERO https://www.crd.york.ac.uk/PROSPERO/ (CRD42021219822).